Emergent is adding two senior leaders to its Quality and Compliance and Contract Development & Manufacturing (CDMO) organizations. 
 
Effective April 1, Coleen Glessner will join Emergent as Executive Vice President with enterprise responsibility for the Global Quality and Ethics and Compliance functions reporting directly to the CEO, Robert Kramer. Glessner joins the company from Alexion Pharmaceuticals where she served as Senior Vice President and Chief Quality Officer.
 
Bill Hartzel is joining Emergent as Senior Vice President for CDMO effective March 14. Hartzel will lead Emergent’s CDMO business, reporting to Chief Operating Officer Adam Havey. Hartzel most recently served as Chief Commercial Officer for Woodstock Sterile Solutions. 
 
“Rigorous quality and compliance practices and the growth of our CDMO business are critical to Emergent’s future success, and I am pleased we have been able to add two experienced and accomplished leaders like Coleen and Bill,” said Emergent CEO Robert G. Kramer. “I also want to thank the individuals who stepped up in interim roles to provide operational continuity and who are ensuring a smooth transition between leaders while continuing to deliver for our patients, customers, and shareholders.”